M30 and M65 as novel biomarkers of advanced prostate cancer

被引：0
|
作者：
Liew, M. P. C. [1 ]
Greystoke, A. [1 ]
Dive, C. [1 ]
Clarke, N. W. [1 ]
机构：
[1] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
来源：
BJU INTERNATIONAL | 2009年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [1] M30 AND M65 AS NOVEL BIOMARKERS IN ADVANCED PROSTATE CANCER
    Liew, M. P. C.
    Greystoke, A.
    Dive, C.
    Clarke, N. W.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 277 - 277
  • [2] PLASMA M30 AND M65 LEVELS IN PATIENTS WITH ADVANCED GASTRIC CANCER: IS THERE AN IMPACT ON SURVIVAL OF PATIENTS?
    Bilici, A.
    Ustaalioglu, B. B. Oven
    Orcun, A.
    Ercan, S.
    Seker, M.
    Kefeli, U.
    Yilmaz, B. E.
    Yildirim, M. E.
    Gezen, C.
    Gumus, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 48 - 48
  • [3] Cell death-based pharmacodynamic biomarkers (M30 and M65): the pros and cons
    Ulukaya, Engin
    ANTI-CANCER DRUGS, 2015, 26 : E5 - E6
  • [4] Clinical significance of serum M30 and M65 levels in patients with breast cancer
    Tas, Faruk
    Karabulut, Senem
    Yildiz, Ibrahim
    Duranyildiz, Derya
    BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (08) : 1135 - 1140
  • [5] Clinical significance of serum M30 and M65 levels in melanoma
    Tas, Faruk
    Karabulut, Senem
    Serilmez, Murat
    Yildiz, Ibrahim
    Sen, Fatma
    Ciftci, Rumeysa
    Duranyildiz, Derya
    MELANOMA RESEARCH, 2013, 23 (05) : 390 - 395
  • [6] M65 AND M30 AS HIGHLY SENSITIVE MARKERS OF ALCOHOLIC STEATOHEPATITIS
    Mueller, S.
    Yagmur, E.
    Stickel, F.
    Seitz, H. K.
    Bantel, H.
    Longerich, T.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S60 - S60
  • [7] APOPTOTIC MARKERS M65 AND M30 PREDICT SURVIVAL IN ALD
    Mueller, S.
    ALCOHOL AND ALCOHOLISM, 2015, 50
  • [8] Levels of Serum M30 and M65 Proteins as Biomarkers of Apoptosis in Children Exposed To Passive Smoking
    Shermatov, Kabil
    Guzel, Bulent
    Kazanasmaz, Halil
    Cebi, Nazime
    KONURALP TIP DERGISI, 2018, 10 (03): : 289 - 293
  • [9] Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors
    Ozturk, Banu
    Coskun, Ugur
    Sancak, Banu
    Yaman, Emel
    Buyukberber, Suleyman
    Benekli, Mustafa
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2009, 9 (05) : 645 - 648
  • [10] M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC
    T. Chu
    L. Jiang
    W. Ying
    B. Han
    Clinical and Translational Oncology, 2017, 19 : 326 - 331
12345